News & Updates
Filter by Specialty:
Women with rheumatic diseases face adverse pregnancy outcomes
Pregnancies in women with rheumatic and systemic autoimmune diseases—including systemic lupus erythematosus, spondyloarthritis, and rheumatoid arthritis—pose significant health risks and are likely to lead to unfavourable outcomes, according to several studies presented at this year’s European Alliance of Associations for Rheumatology (EULAR) Congress.
Women with rheumatic diseases face adverse pregnancy outcomes
09 Jun 2022
Postpartum depression: Another outcome of the COVID-19 pandemic?
Several studies presented at ACOG 2022 have raised the question as to whether postpartum depression (PPD) is one of the mental health outcomes of the COVID-19 pandemic.
Postpartum depression: Another outcome of the COVID-19 pandemic?
08 Jun 2022
Transvaginal sonography accepted by women with PMB if high endometrial Ca detection rate
A recent cross-sectional questionnaire study has shown that women with postmenopausal bleeding (PMB) would select transvaginal sonography to measure endometrial thickness (TVS-ET) over gold-standard hysteroscopy with biopsy if TVS-ET achieved a median endometrial cancer detection rate of 95.0 percent.
Transvaginal sonography accepted by women with PMB if high endometrial Ca detection rate
07 Jun 2022
HRT use tied to reduced COVID-19 death risk
The use of hormonal replacement therapy (HRT) among postmenopausal women may be associated with a reduced risk of mortality after a COVID-19 diagnosis, according to a retrospective study from Sweden.
HRT use tied to reduced COVID-19 death risk
02 Jun 2022
Ectopic pregnancies resolve in around 20 days after methotrexate treatment
Methotrexate treatment helps resolve ectopic pregnancies after a median of 22 days, a recent study has found. Baseline levels of human chorionic gonadotrophin (hCG) may help predict the timing of resolution.
Ectopic pregnancies resolve in around 20 days after methotrexate treatment
31 May 2022
Acid reflux drug fails to show benefit in pre-eclampsia treatment
Omeprazole falls short of improving the maternal circulating profile of sFlt-1 (soluble Fms-like tyrosine kinase-1), PlGF (placental growth factor), and ET-1 (endothelin-1) in women with established pre-eclampsia, as shown in a study.